We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Tubulin beta-III antibody (3D9)
Tubulin beta-4 chain
Tubulin beta-III
Gene name : TUBB3
Tubulin beta-III
Gene name : TUBB3
As low as
$306.10
In stock
Ref
00012791
This constituants of microtubules can be used as house-keeping gene (loading control).
| ID Covalab | mab0047-P |
|---|---|
| Product type | Loading controls, Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | 3D9 |
| Isotype | IgG1 / Kappa |
| Raised in | Mouse |
| Immunogen | beta-Tubulin protein |
| Activity cross reaction | Reacts with human 55 kDa TUBB3 protein. Cross reacts with mouse, rat and other species |
| Species | Hu, Ms, Rat |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Tubulin beta-3 chain |
| Uniprot ID | Q13509 |
| Gene ID | 10381 |
| Applications | ELISA, IHC, IP, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only: IHC 1:100 - 1:500 IP 1:50 - 1:200 WB 1:500 - 1:1000 |
| Publication | Jakobsen JN et al. Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients. Cancer Chemother Pharmacol.b 2013 Nov 13. Jakobsen JN et al. Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer. Eur J Cancer. 2013 Apr 29. Zimling ZG, et al. A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2012 Sep 8. |
Write Your Own Review